Unibest
← Back to patent-cliff list

CAS 137649-69-5

dibenzyl ((2S,3R,4R,5S)-3,4-dihydroxy-1,6-diphenylhexane-2,5-diyl)dicarbamate

Codes: RITO-003, COBI-016

Application context (from source-drug indications)

Chronic hepatitis CParitaprevir/Ombitasvir/RitonavirHepatitis CParitaprevir/Ombitasvir/RitonavirDecompensated cirrhosisParitaprevir/Ombitasvir/RitonavirRenal impairmentParitaprevir/Ombitasvir/RitonavirFibrosisParitaprevir/Ombitasvir/RitonavirEnd-stage renal diseaseParitaprevir/Ombitasvir/RitonavirHIV infectionDarunavir Ethanolate/RitonavirHIV infectionCobicistatNon-small cell lung cancerCobicistatAcquired immunodeficiency syndromeCobicistatHIV infectionRitonavirKaposi's sarcomaRitonavirBreast cancerRitonavir

Source drugs (routes using this intermediate)

DrugTierExpiry
Paritaprevir/Ombitasvir/RitonavirTier C — Watch / trade-
Darunavir Ethanolate/RitonavirTier C — Watch / trade-
CobicistatTier C — Watch / trade-
RitonavirTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.